PL372977A1 - Selektywne dipeptydowe inhibitory kalikreiny - Google Patents

Selektywne dipeptydowe inhibitory kalikreiny

Info

Publication number: PL372977A1
Authority: PL; Poland
Prior art keywords: kallikrein; dipeptide inhibitors; selective dipeptide; selective; inhibitors
Prior art date: 2002-03-08

Application number

PL03372977A

Other languages

English (en)

Other versions

PL209670B1 (pl

Inventor

David Michael Evans

Original Assignee

Ferring B.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-08

Filing date

2003-03-04

Publication date

2005-08-08

2003-03-04 Application filed by Ferring B.V. filed Critical Ferring B.V.

2005-08-08 Publication of PL372977A1 publication Critical patent/PL372977A1/pl

2011-10-31 Publication of PL209670B1 publication Critical patent/PL209670B1/pl

Links

108010016626 Dipeptides Proteins 0.000 title 1
102000001399 Kallikrein Human genes 0.000 title 1
108060005987 Kallikrein Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)

PL372977A 2002-03-08 2003-03-04 Nowy związek, będący acyloaminopiperydyno-1-karboksyamidyną, środek farmaceutyczny zawierający ten związek i zastosowanie tego związku do wytwarzania leku PL209670B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0205527.5A GB0205527D0 (en)	2002-03-08	2002-03-08	Inhibitors

Publications (2)

Publication Number	Publication Date
PL372977A1 true PL372977A1 (pl)	2005-08-08
PL209670B1 PL209670B1 (pl)	2011-10-31

Family

ID=9932619

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL372977A PL209670B1 (pl)	2002-03-08	2003-03-04	Nowy związek, będący acyloaminopiperydyno-1-karboksyamidyną, środek farmaceutyczny zawierający ten związek i zastosowanie tego związku do wytwarzania leku

Country Status (26)

Country	Link
US (1)	US7649000B2 (pl)
EP (1)	EP1483284B1 (pl)
JP (1)	JP4330450B2 (pl)
KR (1)	KR100974633B1 (pl)
CN (1)	CN1274713C (pl)
AR (1)	AR039868A1 (pl)
AT (1)	ATE333463T1 (pl)
AU (1)	AU2003208471B2 (pl)
CA (1)	CA2478099C (pl)
DE (1)	DE60306904T2 (pl)
DK (1)	DK1483284T3 (pl)
EG (1)	EG25482A (pl)
ES (1)	ES2264523T3 (pl)
GB (1)	GB0205527D0 (pl)
IL (2)	IL163710A0 (pl)
MX (1)	MXPA04008523A (pl)
MY (1)	MY130830A (pl)
NO (1)	NO332678B1 (pl)
NZ (1)	NZ534891A (pl)
PL (1)	PL209670B1 (pl)
PT (1)	PT1483284E (pl)
RU (1)	RU2301225C2 (pl)
TW (1)	TWI283685B (pl)
UY (1)	UY27699A1 (pl)
WO (1)	WO2003076458A2 (pl)
ZA (1)	ZA200406856B (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4775259B2 (ja)	2004-03-31	2011-09-21	味の素株式会社	アニリン誘導体
US20090075887A1 (en) *	2007-08-21	2009-03-19	Genzyme Corporation	Treatment with Kallikrein Inhibitors
GB0918924D0 (en) *	2009-10-28	2009-12-16	Vantia Ltd	Azaindole derivatives
US9290485B2 (en)	2010-08-04	2016-03-22	Novartis Ag	N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
GB2494851A (en) *	2011-07-07	2013-03-27	Kalvista Pharmaceuticals Ltd	Plasma kallikrein inhibitors
EP2807156A1 (en)	2012-01-27	2014-12-03	Novartis AG	Aminopyridine derivatives as plasma kallikrein inhibitors
US20140378474A1 (en)	2012-01-27	2014-12-25	Novartis Ag	5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
GB201212081D0 (en)	2012-07-06	2012-08-22	Kalvista Pharmaceuticals Ltd	New polymorph
GB201300304D0 (en)	2013-01-08	2013-02-20	Kalvista Pharmaceuticals Ltd	Benzylamine derivatives
PH12015501492B1 (en)	2013-01-08	2015-09-28	Kalvista Pharmaceuticals Ltd	Benzylamine derivatives
GB2510407A (en)	2013-02-04	2014-08-06	Kalvista Pharmaceuticals Ltd	Aqueous suspensions of kallikrein inhibitors for parenteral administration
EP2999697B1 (en)	2013-05-23	2017-04-19	Kalvista Pharmaceuticals Limited	Heterocyclic derivates
TWI636047B (zh)	2013-08-14	2018-09-21	英商卡爾維斯塔製藥有限公司	雜環衍生物
HUE14755117T2 (hu)	2013-08-14	2018-12-28	Kalvista Pharmaceuticals Ltd	Plazma-kallikrein inhibitorok
GB2517908A (en)	2013-08-14	2015-03-11	Kalvista Pharmaceuticals Ltd	Bicyclic inhibitors
ES2715379T3 (es) *	2013-10-28	2019-06-04	Bicyclerd Ltd	Novedosos polipéptidos
RU2733405C2 (ru)	2014-02-07	2020-10-01	Экзитера Фармасьютикалз Инк.	Терапевтические соединения и композиции
GB201421085D0 (en)	2014-11-27	2015-01-14	Kalvista Pharmaceuticals Ltd	New enzyme inhibitors
GB201421088D0 (en)	2014-11-27	2015-01-14	Kalvista Pharmaceuticals Ltd	New enzyme inhibitors
GB201421083D0 (en)	2014-11-27	2015-01-14	Kalvista Pharmaceuticals Ltd	Enzyme inhibitors
DK3464271T3 (da)	2016-05-31	2020-06-15	Kalvista Pharmaceuticals Ltd	Pyrazolderivater som plasma-kallikreininhibitorer
GB201609607D0 (en)	2016-06-01	2016-07-13	Kalvista Pharmaceuticals Ltd	Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201609603D0 (en)	2016-06-01	2016-07-13	Kalvista Pharmaceuticals Ltd	Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
GB201719881D0 (en)	2017-11-29	2018-01-10	Kalvista Pharmaceuticals Ltd	Solid forms of plasma kallikrein inhibitor and salts thereof
PT3716952T (pt)	2017-11-29	2022-04-14	Kalvista Pharmaceuticals Ltd	Formas de administração que incluem um inibidor de calicreína plasmática
CN113056263A (zh)	2018-10-30	2021-06-29	艾克赛特赫拉制药有限责任公司	治疗化合物和组合物
GB201910125D0 (en)	2019-07-15	2019-08-28	Kalvista Pharmaceuticals Ltd	Treatments of angioedema
GB201910116D0 (en)	2019-07-15	2019-08-28	Kalvista Pharmaceuticals Ltd	Treatments of hereditary angioedema
EP4010333A1 (en)	2019-08-09	2022-06-15	Kalvista Pharmaceuticals Limited	Plasma kallikrein inhibitors
GB2591730A (en)	2019-12-09	2021-08-11	Kalvista Pharmaceuticals Ltd	New polymorphs
GB201918994D0 (en)	2019-12-20	2020-02-05	Kalvista Pharmaceuticals Ltd	Treatments of diabetic macular edema and impaired visual acuity
WO2021198534A1 (en)	2020-04-04	2021-10-07	Oxurion NV	Plasma kallikrein inhibitors for use in the treatment of coronaviral disease
WO2022079446A1 (en)	2020-10-15	2022-04-21	Kalvista Pharmaceuticals Limited	Treatments of angioedema
EP4232031A1 (en)	2020-10-23	2023-08-30	Kalvista Pharmaceuticals Limited	Treatments of angioedema
JP2024505596A (ja)	2021-02-09	2024-02-06	カルビスタ・ファーマシューティカルズ・リミテッド	遺伝性血管性浮腫の治療
WO2023002219A1 (en)	2021-07-23	2023-01-26	Kalvista Pharmaceuticals Limited	Treatments of hereditary angioedema
WO2023144030A1 (en)	2022-01-31	2023-08-03	Oxurion NV	Plasma kallikrein inhibitor therapy for anti-vegf sensitization
WO2023148016A1 (en)	2022-02-04	2023-08-10	Oxurion NV	Biomarker for plasma kallikrein inhibitor therapy response
EP4480545A3 (en)	2022-04-27	2025-02-26	Kalvista Pharmaceuticals Limited	Formulations of a plasma kallikrein inhibitor
WO2024180100A1 (en)	2023-02-27	2024-09-06	Kalvista Pharmaceuticals Limited	New solid form of a plasma kallikrein inhibitor
WO2025153806A1 (en)	2024-01-15	2025-07-24	Kalvista Pharmaceuticals Limited	Methods for determining amidolytic activity
WO2025172692A1 (en)	2024-02-13	2025-08-21	Kalvista Pharmaceuticals Limited	Oral sebetralstat for the treatment of an attack of hereditary angioedema
WO2025172693A1 (en)	2024-02-13	2025-08-21	Kalvista Pharmaceuticals Limited	Oral sebetralstat for the treatment of an attack of hereditary angioedema

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9019558D0 (en) *	1990-09-07	1990-10-24	Szelke Michael	Enzyme inhibitors
AU2882792A (en) *	1991-10-23	1993-05-21	Procter & Gamble Company, The	Tripeptide derivative anti-inflammatory agents
SE9301911D0 (sv) *	1993-06-03	1993-06-03	Ab Astra	New peptide derivatives
GB9318637D0 (en) *	1993-09-08	1993-10-27	Ferring Res Ltd	Enzyme inhibitors

2002
- 2002-03-08 GB GBGB0205527.5A patent/GB0205527D0/en not_active Ceased
2003
- 2003-02-26 TW TW092104061A patent/TWI283685B/zh not_active IP Right Cessation
- 2003-03-03 EG EG2003030209A patent/EG25482A/xx active
- 2003-03-04 CN CNB038054019A patent/CN1274713C/zh not_active Expired - Fee Related
- 2003-03-04 CA CA2478099A patent/CA2478099C/en not_active Expired - Lifetime
- 2003-03-04 DE DE60306904T patent/DE60306904T2/de not_active Expired - Lifetime
- 2003-03-04 JP JP2003574673A patent/JP4330450B2/ja not_active Expired - Fee Related
- 2003-03-04 AU AU2003208471A patent/AU2003208471B2/en not_active Ceased
- 2003-03-04 PL PL372977A patent/PL209670B1/pl unknown
- 2003-03-04 US US10/506,535 patent/US7649000B2/en not_active Expired - Lifetime
- 2003-03-04 EP EP03706759A patent/EP1483284B1/en not_active Expired - Lifetime
- 2003-03-04 MX MXPA04008523A patent/MXPA04008523A/es active IP Right Grant
- 2003-03-04 ES ES03706759T patent/ES2264523T3/es not_active Expired - Lifetime
- 2003-03-04 DK DK03706759T patent/DK1483284T3/da active
- 2003-03-04 WO PCT/GB2003/000908 patent/WO2003076458A2/en not_active Ceased
- 2003-03-04 PT PT03706759T patent/PT1483284E/pt unknown
- 2003-03-04 AT AT03706759T patent/ATE333463T1/de active
- 2003-03-04 IL IL16371003A patent/IL163710A0/xx unknown
- 2003-03-04 NZ NZ534891A patent/NZ534891A/xx not_active IP Right Cessation
- 2003-03-04 KR KR1020047013816A patent/KR100974633B1/ko not_active Expired - Fee Related
- 2003-03-04 RU RU2004126610/04A patent/RU2301225C2/ru not_active IP Right Cessation
- 2003-03-06 AR ARP030100772A patent/AR039868A1/es active IP Right Grant
- 2003-03-06 UY UY27699A patent/UY27699A1/es not_active Application Discontinuation
- 2003-03-07 MY MYPI20030803A patent/MY130830A/en unknown
2004
- 2004-08-24 IL IL163710A patent/IL163710A/en active IP Right Grant
- 2004-08-27 ZA ZA200406856A patent/ZA200406856B/en unknown
- 2004-09-03 NO NO20043695A patent/NO332678B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB0205527D0 (en)	2002-04-24
KR100974633B1 (ko)	2010-08-06
NO20043695L (no)	2004-10-07
US20060052313A1 (en)	2006-03-09
CA2478099A1 (en)	2003-09-18
MY130830A (en)	2007-07-31
AU2003208471B2 (en)	2006-09-28
NZ534891A (en)	2006-03-31
CA2478099C (en)	2011-10-04
TW200403255A (en)	2004-03-01
MXPA04008523A (es)	2004-12-06
CN1639186A (zh)	2005-07-13
ZA200406856B (en)	2005-11-30
JP2005533750A (ja)	2005-11-10
NO332678B1 (no)	2012-12-03
EP1483284B1 (en)	2006-07-19
ATE333463T1 (de)	2006-08-15
EG25482A (en)	2012-01-15
AU2003208471A1 (en)	2003-09-22
DE60306904T2 (de)	2007-02-08
WO2003076458A3 (en)	2003-11-06
IL163710A (en)	2010-12-30
HK1072265A1 (en)	2005-08-19
KR20040089705A (ko)	2004-10-21
ES2264523T3 (es)	2007-01-01
JP4330450B2 (ja)	2009-09-16
IL163710A0 (en)	2005-12-18
WO2003076458A2 (en)	2003-09-18
EP1483284A2 (en)	2004-12-08
DK1483284T3 (da)	2006-10-16
RU2004126610A (ru)	2005-05-27
US7649000B2 (en)	2010-01-19
TWI283685B (en)	2007-07-11
PL209670B1 (pl)	2011-10-31
DE60306904D1 (de)	2006-08-31
CN1274713C (zh)	2006-09-13
RU2301225C2 (ru)	2007-06-20
AR039868A1 (es)	2005-03-09
UY27699A1 (es)	2003-10-31
PT1483284E (pt)	2006-11-30

Publication	Publication Date	Title
IL163710A0 (en)	2005-12-18	Selective dipeptide inhibitors of kallikrein
EP1549316A4 (en)	2008-04-09	HAMMER OF TFGbeta
AU2003261434A8 (en)	2004-02-25	Iminothiazolidinones as inhibitors of hcv replication
PL375359A1 (pl)	2005-11-28	Cykloalkilowe inhibitory działania kanału potasowego
SI2594265T1 (sl)	2016-03-31	CA-IX specifični inhibitorji
IL165475A0 (en)	2006-01-15	Nitrooxyderivatives of eyclooxygenase-2 inhibitors
EP1704142A4 (en)	2008-08-20	PROTEASE INHIBITORS
EP1663279A4 (en)	2009-02-18	MODIFIED PROTEASE INHIBITORS
PL371217A1 (pl)	2005-06-13	Inhibitory integryny alfaVbeta6
AU2003299901A8 (en)	2004-05-04	Thrombin inhibitors
AU2003269984A8 (en)	2004-03-11	Protease inhibitors
PL373523A1 (pl)	2005-09-05	Indol-2-ony jako selektywne inhibitory cyklooksygenazy-2
AU2003231865A8 (en)	2003-12-19	Alpha acyloxyacetamides for kallikrein and urokinase inhibition
EP1658274A4 (en)	2008-11-12	INHIBITORS OF CATHEPSIN S
AU2003304374A8 (en)	2005-02-14	Peptide inhibitors of beta-lactamases
AU2003249320A8 (en)	2004-02-09	Novel inhibitors of ubiquitin isopeptidases
AU2003263738A8 (en)	2003-12-02	Protease inhibitors
EP1677782A4 (en)	2010-11-17	INHIBITORS OF CATHEPSIN S
AU2003304496A8 (en)	2005-04-27	Protease inhibitors
AU2003233642A8 (en)	2003-12-12	Protease inhibitors
AU2003265240A8 (en)	2003-12-22	Protease inhibitors
AU2003269878A8 (en)	2003-12-22	Protease inhibitors
PL353109A1 (pl)	2003-10-06	Sposób otrzymywania alfa-1-inhibitora proteinaz
GB0225854D0 (en)	2002-12-11	Inhibitors of complement activation
GB0226149D0 (en)	2002-12-18	Inhibitors